COAG
Hemab Therapeutics Holdings, Inc.
Ra Capital Management, L.P. bought $52.2M of Hemab Therapeutics Holdings, Inc.
Director and 10% owner
Bought$52,222,946
$18.39Price
2,840,429Shares
+82%Stake
What COAG did for a copier
- $1,000 copied at Thu, May 7 open, $24.96
- $1,272
- S&P 500, same days
- +1.3%
Measured over 30 trading days, to the Jun 22 close.
Ra Capital Management, L.P.'s record
63 other buys with 3 months of prices since 2016: on average −1.7% against the S&P 500, and 22 of 63 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, May 4. Filed Wed, May 6, 7:16 PM ET, after the close. Returns use the May 7 open and the Jun 22 close. Not investment advice.